Osaka, Japan

Kaoru Tashiro



 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kaoru Tashiro: Innovator in Medical Compounds

Introduction

Kaoru Tashiro is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical compounds, holding a total of 4 patents. His work focuses on developing innovative solutions for various medical conditions, particularly autoimmune diseases and related disorders.

Latest Patents

Tashiro's latest patents include an amine compound that is useful for medical purposes. This compound demonstrates a superior ability to decrease peripheral blood lymphocytes, making it valuable for treating autoimmune diseases, preventing organ rejection, and addressing graft-versus-host disease. Another notable patent is an amide derivative that serves as a therapeutic drug for autoimmune diseases and osteoarthritis. This compound effectively suppresses the production of induction type MMPs, particularly MMP-9, while not affecting hemostatic type MMP-2.

Career Highlights

Kaoru Tashiro is associated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Tashiro collaborates with esteemed colleagues, including Seigo Ishibuchi and Hidemasa Hikawa. Their combined expertise contributes to the innovative research being conducted at Mitsubishi Tanabe Pharma Corporation.

Conclusion

Kaoru Tashiro's contributions to medical innovation through his patents highlight his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of autoimmune diseases and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…